Bacilliferous Pulmonary Tuberculosis clinical trials

Explore recruiting bacilliferous pulmonary tuberculosis clinical trials.

Also recruiting in Europe

Bacilliferous Pulmonary Tuberculosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Bacilliferous Pulmonary Tuberculosis trials by city

Bacilliferous Pulmonary Tuberculosis in Toronto Bacilliferous Pulmonary Tuberculosis in Vancouver Bacilliferous Pulmonary Tuberculosis in Montreal Bacilliferous Pulmonary Tuberculosis in Calgary Bacilliferous Pulmonary Tuberculosis in Edmonton Bacilliferous Pulmonary Tuberculosis in Ottawa Bacilliferous Pulmonary Tuberculosis in Winnipeg Bacilliferous Pulmonary Tuberculosis in Quebec City Bacilliferous Pulmonary Tuberculosis in Hamilton Bacilliferous Pulmonary Tuberculosis in Kitchener Bacilliferous Pulmonary Tuberculosis in London Bacilliferous Pulmonary Tuberculosis in Halifax Bacilliferous Pulmonary Tuberculosis in New York Bacilliferous Pulmonary Tuberculosis in Los Angeles Bacilliferous Pulmonary Tuberculosis in Chicago Bacilliferous Pulmonary Tuberculosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease